Results 1 to 10 of about 172,098 (309)

Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms [PDF]

open access: greenAdvances in Anatomic Pathology, 2018
The diagnosis of a neurofibroma or a malignant peripheral nerve sheath tumor (MPNST) often raises the question of whether the patient has the genetic disorder neurofibromatosis type 1 (NF1) as well as how this will impact the patient’s outcome, what their risk is for developing additional neoplasms and whether treatment options differ for NF1 ...
Jody F, Longo   +3 more
semanticscholar   +6 more sources

Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system [PDF]

open access: greenBrain Research Bulletin, 2012
Neurofibromatosis type 1 (NF1), the most common genetic disorder affecting the human nervous system, is characterized by the development of multiple benign Schwann cell tumors in skin and large peripheral nerves. These neoplasms, which are termed dermal and plexiform neurofibromas respectively, have distinct clinical courses; of particular note ...
Nicole M, Brossier, Steven L, Carroll
semanticscholar   +5 more sources

Immunolocalization of Laminin in Neoplasms of the Central and Peripheral Nervous Systems [PDF]

open access: bronzeJournal of Neuropathology and Experimental Neurology, 1985
Laminin is a basement membrane glycoprotein that is expressed in vitro by immature and neoplastic astrocytes. The expression of laminin in vivo was examined immunohistochemically in normal adult brain and 90 neoplasms of the central and peripheral nervous systems.
R D, McComb, D D, Bigner
semanticscholar   +4 more sources

The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.

open access: yesThe American journal of pathology, 2016
Comprehensive genomic analyses of common nervous system cancers provide new insights into their pathogenesis, diagnosis, and treatment. Although analogous studies of rare nervous system tumors are needed, there are major barriers to performing such studies.
S. Carroll
openaire   +3 more sources

Large schwannoma of the median nerve at the distal forearm [PDF]

open access: yesVojnosanitetski Pregled, 2023
Introduction. Schwannoma, also known as neurilemmoma, is a rare but one of the most common tumors of the peripheral nerves. It originates from Schwann cells of the peripheral nerve sheaths. Schwannoma mostly occurs in adults between 20 to 70 years of age.
Vulović Dejan   +8 more
doaj   +1 more source

Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2

open access: yesPediatric Neurosurgery, 2023
Background: Neurofibromatosis type 1 and neurofibromatosis type 2 are unrelated, distinct genetic disorders characterized by the development of central and peripheral nervous system tumors.
Chelsea Kotch   +3 more
semanticscholar   +1 more source

Immunohistochemical Study of Ki-67 Labelling Index in Neoplasms of Central Nervous System [PDF]

open access: yesNational Journal of Laboratory Medicine, 2022
Introduction: The central nervous system tumours show a varied histopathological spectrum. The cell proliferation index may provide an objective method for assessing tumour biology. The Ki-67 is considered to be the most reliable proliferative marker
Anuradha G Patil   +3 more
doaj   +1 more source

Surgery of Schwannoma in the upper limb – sensitivity and specificity of preoperative magnetic resonance imaging and relation between tumour size and symptoms

open access: yesBMC Musculoskeletal Disorders, 2023
Background Benign peripheral nerve tumours consist of different types, most commonly Schwannomas. Preoperative Magnetic Resonance Imaging (MRI) is commonly performed before surgery and Pathoanatomical Diagnosis (PAD) confirms the diagnosis. Our aims were
Emanuel Istefan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy